Results 91 to 100 of about 10,738 (252)

Not Your Typical Ulcerative Colitis Patient [PDF]

Modern Medicine
Background: Extraintestinal manifestations (EIMs) of inflammatory bowel diseases (IBDs) are a common and debilitating feature of disease, occurring in up to 40% of patients with IBD.
Teodora SPATARU, Ana STEMATE, Roxana SADAGURSCHI, Lucian NEGREANU   +3 more
doaj   +1 more source

Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis [PDF]

, 2001
S Kane
openalex   +2 more sources

Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel disease

JGH Open, 2019
Background and Aim The literature on medication adherence in patients with inflammatory bowel disease (IBD) is heterogeneous. The present study aimed to identify the rates and predictors of nonadherence to medications in IBD. Methods This cross‐sectional
Sanjeevani K Tomar, Saurabh Kedia, Namrata Singh, Ashish D Upadhyay, Nagesh Kamat, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Saransh Jain, Govind Makharia, Vineet Ahuja   +10 more
doaj   +1 more source

Maintaining remission in ulcerative colitis – role of once daily extended-release mesalamine [PDF]

, 2011
The aminosalicylates (5-ASA; also referred to as mesalamine-based agents) are considered as first-line in the maintenance of remission of mild to moderate ulcerative colitis (UC).
Cohen, Russell D, Oliveira, Lilliana
core   +3 more sources

Anti-oxidant and anti-inflammatory potential of different polymer-based mesalamine delayed-release granules in TNBS-induced ulcerative colitis in wistar rats

Saudi Pharmaceutical Journal
Ulcerative colitis (UC) is an inflammatory condition of colon characterized by severe damage to the innermost colon tissues. A number of studies described the use of medication delivery systems based on natural polymers like polysaccharides for the ...
Imtiyaz Ahmed Najar, Archana Sharma, Abdulrahman Alshammari, Thamer H. Albekairi, Metab Alharbi, Taief Ahmad Dar, Zulfkar Latief Qadrie, Atul Kabra, A.M.J Newton, Manish Kumar   +9 more
doaj  

Ulcerative proctitis: an update on the pharmacotherapy and management. [PDF]

, 2014
Introduction: Ulcerative colitis (UC) presents as proctitis in approximately a quarter of the patients. It may progress into left-sided or extensive colitis in up to 50% of cases upon long-term follow-up.Areas covered: Currently available data on ...
Gecse, Krisztina, Lakatos, Péter László   +1 more
core   +1 more source

Distal Ulcerative Colitis Refractory to Rectal Mesalamine: Role of Transdermal Nicotine versus Oral Mesalamine

Canadian Journal of Gastroenterology, 2002
BACKGROUND: Distal ulcerative colitis usually responds to treatment with rectal mesalamine, but the management of refractory cases is poorly defined.AIM: To evaluate the possible therapeutic benefit of transdermal nicotine versus oral mesalamine.PATIENTS AND METHODS: Thirty patients with left-sided ulcerative colitis unresponsive to treatment with a ...
Guslandi M, Frego R, Viale E, TESTONI , PIER ALBERTO   +3 more
openaire   +5 more sources

Mesalamine in pediatric inflammatory bowel disease: A 10-year experience [PDF]

, 1996
Ian D. DʼAgata, Tsafrir Vanounou, Ernest G. Seidman   +2 more
openalex   +1 more source

Endoscopic and clinicopathological features of segmental colitis associated with diverticulosis

DEN Open
Objectives Segmental colitis associated with diverticulosis (SCAD) has close endoscopic and pathological similarities to ulcerative colitis (UC) and Crohn's disease. Clinical data on SCAD are limited in Japan.
Kazuhiko Obata, Kan Uchiyama, Ryuzo Murai   +2 more
doaj   +1 more source

2083 Mesalamine-Induced Myocarditis

American Journal of Gastroenterology, 2019
INTRODUCTION: Mesalamine is a widely used medication for treatment in patients with ulcerative colitis (UC). A rare adverse effect (AE) is mesalamine-induced myocarditis (MIM). A high index of suspicion is essential for prompt diagnosis and prevention of significant morbidity.
Kambiz Kadkhodayan, Tyler Putnam, Erica P. Turse   +2 more
openaire   +3 more sources